Top

Reactions Weekly

Published in:

01-02-2021 | Ribavirin | Case report

Ledipasvir/sofosbuvir

Subarachnoid-haemorrhage, brain stem haemorrhage and development of drug resistance: 11 case reports

Published in: Reactions Weekly | Issue 1/2021

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Mizokami M, et al. Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan. Journal of Viral Hepatitis 28: 129-141, No. 1, Jan 2021. Available from: URL: http://doi.org/10.1111/jvh.13395

Title: Ledipasvir/sofosbuvir
Subarachnoid-haemorrhage, brain stem haemorrhage and development of drug resistance: 11 case reports
Publication date: 01-02-2021
Publisher: Springer International Publishing
Keywords: Ribavirin
Simeprevir
Ledipasvir
Hepatocellular Carcinoma
Hepatitis C
Hepatocellular Carcinoma
Hypertension
Hypertension
Published in: Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-021-91320-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Ledipasvir/sofosbuvir

Subarachnoid-haemorrhage, brain stem haemorrhage and development of drug resistance: 11 case reports

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2021

Multiple drugs

Opioid analgesic use in first trimester increases risk of cleft palate

Multiple drugs

Mycophenolate mofetil/tacrolimus/unspecified corticosteroids

Isotretinoin

Sevoflurane/nitrous oxide/oxygen